Device Urological

Injecsure

Payments companies reported to CMS as associated with Injecsure. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,800associated payments (2023-2025)
10clinicians with associated payments
1company reporting

By year

2025 $4,800

Payments reported as associated with Injecsure, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Urology $2,500
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $1,500
Obstetrics & Gynecology $800

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Injecsure

These are the largest totals companies reported as associated with Injecsure. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Steven Bernstein Edina, MN Urology $1,500.00
Leila Tabibian Saint Paul, MN Urology $500.00
Jennifer Schmitt Saint Paul, MN Obstetrics & Gynecology $500.00
Nissrine Nakib Minneapolis, MN Urology $500.00
Akira Gillingham Chicago, IL Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $300.00
Barry Jarnagin Franklin, TN Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $300.00
Hannah Milthorpe Bethlehem, PA Obstetrics & Gynecology $300.00
George Lazarou Mineola, NY Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $300.00
Matthew Barker Sioux Falls, SD Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $300.00
Vincent Lucente Allentown, PA Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $300.00

Prescribed Injecsure?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.